USER FOCUS
At Haselmeier, our mission is to create products enabling a convenient and comfortable experience. This is why patient feedback is integrated early in our device designs. Early concepts are prototyped for testing and Human Factors studies to capture the handling needs and skills of potential users. This knowledge is integrated into the device design to provide successful administration of the drug product and a positive user experience.

BRIDGE TO MARKET
Successful development and industrialization of drug delivery devices is dependent upon the understanding and execution of today’s technical, regulatory and operational requirements. At Haselmeier we provide integrated design, development and industrialization services to help you bridge your serial product into the market. Our qualified design control process, certified quality system, regulatory expertise, solid network of partners and strong manufacturing operations are all designed to achieve your expectations. Together we enable a smooth market introduction for your commercial drug delivery device. 

MANUFACTURING & LIFECYCLE PARTNER
We understand that each customer has individual and specific requirements for their product. Regardless of your requirements, Haselmeier applies the highest quality standard for manufacturing your drug delivery device to ensure a reliable and reproducible manufacturing and quality process. We work continuously with our customers to identify product improvements at all stages of the product’s lifecycle to provide a safe and state-of-the art drug delivery device.

Drug Delivery. Tailormade.

Advertorial

Go to article: Home | Small Robot, Big PlansGo to article: Accurate Biometrics: Company InsightGo to article: Accurate BiometricsGo to article: In this issueGo to article: SHL Group Company InsightGo to article: SHL GroupGo to article: ContentsGo to article: HaselmeierGo to article: Haselmeier AdvertorialGo to article: Haselmeier Company InsightGo to article: NewsGo to article: velixX System DevelopmentGo to article: velixX Company InsightGo to article: Japanese drug delivery devices market to reach $3.4bn by 2023Go to article: Frankfurt Laser CompanyGo to article: Frankfurt Laser Company Company InsightGo to article: Cardiovascular medicine: ready for the digital era?Go to article: NV BekaertGo to article: KonplanGo to article: Continuous glucose monitoring: a milestone for US diabetes careGo to article: Formacoat Company InsightGo to article: Formacoat Medical CoatingGo to article: With only the US market left, can Bayer’s Essure device survive?Go to article: TRICOR SystemsGo to article: Bel FuseGo to article: The future of artificial intelligence in healthcareGo to article: Micronit MicrofluidicsGo to article: Micronit Microfluidics Company InsightGo to article: Designing medical devices for emerging marketsGo to article: Protomatic MedicalGo to article: Protomatic Company InsightGo to article: The road to market for the world's smallest surgical robotGo to article: Traco PowerGo to article: MIKRONGo to article: Can connected technologies solve the problem of drug adherence?Go to article: Accumold Company InsightGo to article: Accumold Micro Molding SolutionsGo to article: Sab BroeckskesGo to article: Upcoming events for the medical technology industryGo to article: Outsourcing in Clinical Trials: Medical Devices Europe 2018Go to article: VanciveGo to article: Linemaster MedicalGo to article: Linemaster Medical Company InsightGo to article: Next issue previewGo to article: Micro Systems TechnologiesGo to article: CIM medGo to article: CIM med Company InsightGo to article: Maxon Motor AGGo to article: Mettler ToledoGo to article: Telemed Ultrasound Medical Systems